›1.independentAn anti-TIGIT antibody, or antigen-binding fragment thereof, comprising a light chain comprising an HVR-L1 comprising SEQ ID NO: 23, an HVR-L2 compris…+4

›6.independentAn anti-TIGIT antibody, or antigen-binding fragment thereof, comprising a light chain comprising the amino acid sequence set forth in SEQ ID NO: 21 an…

›7.independentAn anti-TIGIT antibody, or antigen-binding fragment thereof, comprising a light chain comprising an HVR-L1 comprising SEQ ID NO: 31, an HVR-L2 compris…+4

›12.independentAn anti-TIGIT antibody, or antigen-binding fragment thereof, comprising a light chain comprising the amino acid sequence set forth in SEQ ID NO: 29 an…

Classifications

10 codes

IPC · International Patent Classification

Section A — Human necessities

A61K39/00

Section C — Chemistry; metallurgy

C07K16/00
C07K14/705
C12P21/08
C07K16/18
C07K14/47
C07K16/28

Section G — Physics

G01N33/50
G01N33/569
G01N33/564

Claim changes

Soon

Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

Pendency

3.0 y

1,100 days filing → grant

Office actions

after a restriction

Responses

1 RCE

Examiner

Amy E Juedes

art unit 1644 · TC 1600

Law firm

Law firm · Log in to unlock

Citations: 265 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Priority chain

2 priority documents

Priority

26 Sep 2008

earliest claimed

›Priority documents — 2

Type	Document	Date
provisional	US 61194271	26 Sep 2008
related publication	US 20170145093 A1	25 May 2017

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.